Indrayani Biotech posts consolidated PAT of Rs. 1.14 crore in Q3FY22

INDRAYANI BIOTECH LTD. has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 15.4035 crores during the period ended December 31, 2021 as compared to Rs. 14.8895 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 1.1453 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 1.0401 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.33 for the period ended December 31, 2021 as compared to Rs. 0.30 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹15.4035 crs	₹14.8895 crs	3.45%
Net Profit	₹1.1453 crs	₹1.0401 crs	10.11%
EPS	₹0.33	₹0.30	10.00%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs.15.4035 crores during the period ended December 31, 2021 as compared to Rs.5.8195 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.1.1453 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-1.7449 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.33 for the period ended December 31, 2021 as compared to Rs.-0.51 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹15.4035 crs	₹5.8195 crs	164.69%
Net Profit	₹1.1453 crs	₹-1.7449 crs	165.64%
EPS	₹0.33	₹-0.51	164.71%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.44.5405 crores during the 9 Months period ended December 31, 2021 as compared to Rs.14.0419 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.2.8306 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-7.9678 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.0.83 for the 9 Months period ended December 31, 2021 as compared to Rs.-2.33 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹44.5405 crs	₹14.0419 crs	217.20%
Net Profit	₹2.8306 crs	₹-7.9678 crs	135.53%
EPS	₹0.83	₹-2.33	135.62%

Shares of INDRAYANI BIOTECH LTD. was last trading in BSE at Rs. 26.70 as compared to the previous close of Rs. 25.45. The total number of shares traded during the day was 29413 in over 460 trades.

The stock hit an intraday high of Rs. 27.60 and intraday low of 25.80. The net turnover during the day was Rs. 779621.00.

Source : Equity Bulls

Keywords

IndrayaniBiotech Q3FY22 9MFY22 ResultUpdate